Ocumension Therapeutics 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Dec 7, 2023
Insider Transaction Report
Form 4
Ocumension Therapeutics
10% Owner
Transactions
- Sale
common stock
2023-12-05$19.91/sh−733,758$14,609,122→ 2,276,963 total - Sale
common stock
2023-12-06$18.41/sh−266,242$4,901,515→ 2,010,721 total